Masayuki Kobayashi¹, Toyotaka Kawamata², Junya Makiyama², Kazuaki Yokoyama², Yoichi Imai², Arinobu Tojo^1,2 (1.Division of Molecular therapy, IMSUT, Tokyo, Japan, 2.Department of Haematology/Oncology, IMSUT Hospital, Tokyo, Japan)

Ichiro Kawashima, Jun Suzuki, Takuma Kumagai, Megumi Suzuki, Megumi Koshiishi, Kei Nakajima, Keita Kirito (Department of Hematology and Oncology, University of Yamanashi, Yamanashi-ken, Japan)

Miho Ogawa¹, Kazuaki Yokoyama², Nobuhiro Tsukada³, Takao Yogo³, Kanya Kondoh¹, Tomomi Takei¹, Sousuke Nakamura¹, Mika Ito¹, Asako Kobayashi¹, Nozomi Yusa⁴, Mako Yamamoto⁵, Rika Kasajima⁶, Eigo Shimizu⁵, Rui Yamaguchi⁷, Seiya Imoto⁶, Satoru Miyano^5,6, Arinobu Tojo^1,2 (1.Division of Molecular Therapy, IMSUT, The University of Tokyo, 2.Department of Hematology/Oncology, IMSUT Hospital, The University of Tokyo, 3.Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan, 4.Department of Applied Genomics, IMSUT Hospital, The University of Tokyo, 5.Human Genome Center, IMSUT, The University of Tokyo, 6.Health Intelligence Center, IMSUT, The University of Tokyo, 7.Division of Cancer Systems Biology Aichi Cancer Center Research Institute)

Yasuyuki Takahashi, Takayuki Tabayashi, Ken Naganuma, Yuka Tanaka, Yuta Kimura, Tatsuki Tomikawa, Junichi Watanabe, Tomoe Anan, Morihiko Sagawa, Reiko Nakaseko, Michihide Tokuhira, Masahiro Kizaki (Department of Hematology, Saitama Medical Center, Saitama Medical University)

Junichi Kameoka¹, Masahiro Kobayashi¹, Yuko Shirota¹, Shori Abe¹, Jun Nomura¹, Takao Kodera¹, Yumiko Oka¹, Yoko Okitsu^1,2, Noriko Fukuhara³, Yasushi Onishi³, Hiroshi Fujii³, Tomonori Ishii³, Shinichiro Takahashi², Hideo Harigae³ (1.Hematology and Rheumatology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, 2.Laboratory Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan, 3.Tohoku University Graduate School of Medicine, Sendai, Japan)

Takeshi Okatani¹, Yuta Katayama¹, Tatsuya Terasaki¹, Takuya Nunomura¹, Fumiaki Jinnouchi¹, Ryota Imanaka¹, Kohei Kyo¹, Mitsuhiro Itagaki¹, Shinya Katsutani¹, Tsuyoshi Muta², Koji Iwato³, Megumu Fujiwara⁴, Hideki Asaoku¹, Taiichi Kyo⁵ (1.Hematol., Hiroshima Red Cross Hosp. & Atomic-bomb Survivors Hosp., Japan, 2.Transfusion, Hiroshima Red Cross Hosp. & Atomic-bomb Survivors Hosp., Japan, 3.Labo., Hiroshima Red Cross Hosp. & Atomic-bomb Survivors Hosp., Japan, 4.Pathol., Hiroshima Red Cross Hosp. & Atomic-bomb Survivors Hosp., Japan, 5.Hematol., Itsukaichi Memorial Hosp., Japan)